Jacob Steven Leach is EVP, Chief Operating Officer of DEXCOM INC. Currently has a direct ownership of 264,915 shares of DXCM, which is worth approximately $19.9 Million. The most recent transaction as insider was on Sep 09, 2024, when has been sold 746 shares (Common Stock) at a price of $69.15 per share, resulting in proceeds of $51,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K
0.25% 3M change
2.04% 12M change
Total Value Held $19.9 Million

Jacob Steven Leach Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 09 2024
SELL
Open market or private sale
$51,585 $69.15 p/Share
746 Reduced 0.28%
264,915 Common Stock
Jun 10 2024
SELL
Open market or private sale
$85,712 $115.05 p/Share
745 Reduced 0.28%
265,577 Common Stock
Mar 12 2024
SELL
Open market or private sale
$1,967,627 $134.41 p/Share
14,639 Reduced 5.07%
273,913 Common Stock
Mar 12 2024
SELL
Bona fide gift
-
7,736 Reduced 2.82%
266,177 Common Stock
Mar 08 2024
BUY
Grant, award, or other acquisition
-
26,053 Added 8.28%
288,552 Common Stock
Jan 16 2024
SELL
Open market or private sale
$491,800 $123.63 p/Share
3,978 Reduced 1.49%
262,499 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
9,697 Added 3.51%
266,477 Common Stock
Dec 18 2023
SELL
Sale (or disposition) back to the issuer
$357,264 $121.85 p/Share
2,932 Reduced 1.13%
256,780 Common Stock
Apr 20 2023
SELL
Open market or private sale
$3,845,500 $125.0 p/Share
30,764 Reduced 10.59%
259,613 Common Stock
Mar 10 2023
SELL
Sale (or disposition) back to the issuer
$1,794,542 $111.4 p/Share
16,109 Reduced 5.26%
290,377 Common Stock
Mar 08 2023
BUY
Grant, award, or other acquisition
-
25,397 Added 7.65%
306,486 Common Stock
Mar 06 2023
SELL
Open market or private sale
$2,082,749 $114.79 p/Share
18,144 Reduced 6.06%
281,089 Common Stock
Mar 09 2022
SELL
Sale (or disposition) back to the issuer
$1,735,094 $406.06 p/Share
4,273 Reduced 5.41%
74,746 Common Stock
Mar 08 2022
BUY
Grant, award, or other acquisition
-
6,741 Added 7.86%
79,019 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
-
2,925 Added 3.89%
72,247 Common Stock
Sep 09 2021
SELL
Open market or private sale
$684,167 $541.7 p/Share
1,263 Reduced 1.79%
69,322 Common Stock
Jul 30 2021
SELL
Open market or private sale
$5,761,873 $476.7 p/Share
12,087 Reduced 14.63%
70,554 Common Stock
Jun 09 2021
SELL
Open market or private sale
$8,988,225 $395.0 p/Share
22,755 Reduced 21.59%
82,641 Common Stock
Mar 10 2021
SELL
Open market or private sale
$1,942,711 $362.92 p/Share
5,353 Reduced 4.83%
105,396 Common Stock
Mar 08 2021
BUY
Grant, award, or other acquisition
-
7,171 Added 6.08%
110,749 Common Stock

Also insider at

SNES
SenesTech, Inc. Basic Materials
JSL

Jacob Steven Leach

EVP, Chief Operating Officer
Phoenix, AZ

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Track Activities on DXCM